Does Long-Term Acyclovir Harm Kidneys?
Acyclovir, an antiviral used for herpes infections, can cause kidney damage with prolonged use, mainly through crystal-induced nephropathy. The drug precipitates as crystals in renal tubules when urine is concentrated or pH is low, leading to acute kidney injury (AKI). Studies show this risk rises with high doses (>2g/day), dehydration, or pre-existing kidney issues. In one review of 55 cases, 73% involved IV acyclovir and resolved after stopping the drug, but chronic use heightens cumulative risk.[1][2]
What Are the Common Kidney Side Effects?
- Acute tubular necrosis: From crystal obstruction, causing rising creatinine and oliguria; occurs in 12-48% of high-risk patients on IV therapy.[3]
- Glomerular filtration drop: Long-term oral use (e.g., 400mg 2-3x daily for suppression) links to chronic kidney disease (CKD) progression in case reports, especially in elderly or HIV patients.[4]
- Reversible vs. permanent: Most AKI reverses within days of hydration and discontinuation, but repeated exposure can scar tubules permanently.[1]
Monitoring includes baseline creatinine, urine output, and serum levels; IV forms need slow infusion over 1-2 hours.[2]
Who Is Most at Risk?
Patients with:
- CKD stage 3+ (eGFR <60 mL/min): Dose-adjust to 200-400mg 2x daily.
- Dehydration or low urine pH (<6).
- Concurrent nephrotoxins like NSAIDs or aminoglycosides.
- IV use exceeding 10-15mg/kg/day.
A 2020 meta-analysis found odds ratio of 4.7 for AKI in those with baseline impairment.[5] Oral suppressive therapy (years-long for HSV) shows lower incidence but still warrants annual eGFR checks.[4]
How to Prevent Kidney Issues on Long-Term Acyclovir?
- Hydrate aggressively: 2-3L/day fluids to dilute urine.
- Alkalinize urine with sodium bicarbonate if pH <7.
- Use lowest effective dose; switch to valacyclovir (better absorbed, lower peak levels) when possible.
- Regular labs: Creatinine every 3-6 months.
Guidelines from IDSA recommend these for chronic suppression in transplant or immunocompromised patients.[6]
Evidence from Studies and Real-World Data
Retrospective data from 1,000+ patients on long-term oral acyclovir (up to 10 years) report 5-10% CKD progression, vs. 2% in controls, adjusted for age/comorbidities.[4] IV cases dominate acute reports (e.g., VA hospital study: 20% AKI rate).[3] No large RCTs exist due to ethical issues, but cohort studies confirm dose/duration correlation.
Alternatives for Long-Term Antiviral Needs?
Valacyclovir or famciclovir have similar efficacy for HSV suppression with potentially lower nephrotoxicity (better bioavailability reduces crystal formation).[7] For resistant cases, foscarnet is more toxic. Discuss with provider for personalized switch.
[1] Acute Kidney Injury Associated with Acyclovir: A Retrospective Analysis
[2] Acyclovir Nephrotoxicity
[3] Incidence of Acyclovir-Induced Nephrotoxicity
[4] Long-Term Acyclovir and Renal Function
[5] Meta-Analysis of Acyclovir AKI Risk
[6] IDSA Guidelines for HSV Management
[7] Valacyclovir vs Acyclovir: Renal Safety